These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3909538)

  • 1. Ultrafiltration compared with equilibrium dialysis in the determination of unbound phenytoin in plasma.
    Koike Y; Magnusson A; Steiner E; Rane A; Sjöqvist F
    Ther Drug Monit; 1985; 7(4):461-5. PubMed ID: 3909538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated determination of free phenytoin in human plasma with on-line equilibrium dialysis and column-switching high-performance liquid chromatography.
    Andresen AT; Rasmussen KE; Rugstad HE
    J Chromatogr; 1993 Nov; 621(2):189-98. PubMed ID: 8294541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EMIT FreeLevel ultrafiltration technique compared with equilibrium dialysis and ultracentrifugation to determine protein binding of phenytoin.
    Oellerich M; Müller-Vahl H
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():61-70. PubMed ID: 6705428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability of phenytoin protein binding in epileptic patients.
    DeMonaco HJ; Lawless LM
    Arch Neurol; 1983 Aug; 40(8):481-3. PubMed ID: 6347141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of an ultrafiltration-fluorescence polarization immunoassay for monitoring unbound phenytoin.
    Argyle JC; Kinniburgh DW; Costa R; Jennison T
    Ther Drug Monit; 1984; 6(1):117-20. PubMed ID: 6710555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temperature effect on serum protein binding kinetics of phenytoin in monotherapy patients with epilepsy.
    Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
    Eur J Pharm Biopharm; 1999 May; 47(3):295-8. PubMed ID: 10382115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsy.
    Barth N; Alván G; Borgå O; Sjöqvist F
    Clin Pharmacokinet; 1976; 1(6):444-52. PubMed ID: 1024769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of plasma unbound drug concentrations in adjusting phenytoin doses.
    Bachmann K; Voeller K; Forney R
    Ther Drug Monit; 1984; 6(2):173-8. PubMed ID: 6740736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring unbound versus total vancomycin concentrations in serum and plasma: methodological issues and relevance.
    Stove V; Coene L; Carlier M; De Waele JJ; Fiers T; Verstraete AG
    Ther Drug Monit; 2015 Apr; 37(2):180-7. PubMed ID: 25072945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma protein binding of phenytoin in 100 epileptic patients.
    Peterson GM; McLean S; Aldous S; Von Witt RJ; Millingen KS
    Br J Clin Pharmacol; 1982 Aug; 14(2):298-300. PubMed ID: 7104186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a rapid ultrafiltration technique for determination of quinidine protein binding and comparison with equilibrium dialysis.
    Ha HR; Vozeh S; Follath F
    Ther Drug Monit; 1986; 8(3):331-5. PubMed ID: 3529516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of free thyroid hormones in animal serum/plasma using ultrafiltration in combination with ultra-fast liquid chromatography-tandem mass spectrometry.
    Tanoue R; Kume I; Yamamoto Y; Takaguchi K; Nomiyama K; Tanabe S; Kunisue T
    J Chromatogr A; 2018 Mar; 1539():30-40. PubMed ID: 29395158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unbound plasma phenytoin concentrations measured using enzyme immunoassay technique on the cobas MIRA analyser--in vivo effect of valproic acid.
    Sallustio BC; Morris RG
    Ther Drug Monit; 1992 Feb; 14(1):9-13. PubMed ID: 1546396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Beckman TL-100 ultracentrifuge with the Amicon Centrifree Micropartition filters to determine protein-free phenytoin concentrations.
    Zysset T; Hegel A
    Ther Drug Monit; 1987 Dec; 9(4):433-8. PubMed ID: 3424409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentrations of unbound phenytoin in the management of epilepsy.
    Kilpatrick CJ; Wanwimolruk S; Wing LM
    Br J Clin Pharmacol; 1984 May; 17(5):539-46. PubMed ID: 6733002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of free disopyramide plasma concentrations using ultrafiltration and enzyme multiplied immunoassay.
    Raghow G; Meyer MC; Straughn AB
    Ther Drug Monit; 1985; 7(4):466-71. PubMed ID: 3909539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of temperature on binding characteristics of phenytoin to serum proteins in monotherapy adult patients with epilepsy.
    Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
    Am J Ther; 2000 Jan; 7(1):11-5. PubMed ID: 11319568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of equilibrium dialysis, ultrafiltration, and gel permeation chromatography for the determination of free fractions of phenobarbital and phenytoin.
    Melten JW; Wittebrood AJ; Willems HJ; Faber GH; Wemer J; Faber DB
    J Pharm Sci; 1985 Jun; 74(6):692-4. PubMed ID: 4020659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo binding characteristics of phenytoin to serum proteins in monotherapy pediatric patients with epilepsy.
    Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Itokazu N; Sugimoto T
    Int J Clin Pharmacol Ther; 2000 Jan; 38(1):25-9. PubMed ID: 10667833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid.
    Odar-Cederlöf I; Borga O
    Clin Pharmacol Ther; 1976 Jul; 20(1):36-47. PubMed ID: 1277724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.